Anti-BCR-ABL (7c6)

Anti-BCR-ABL (7c6), Recombinant, IgG4-S228P kappa, Host: Human
Artikelnummer
ABAAb00817-13.12-BT
Verpackungseinheit
1 mg
Hersteller
Absolute Antibody

Verfügbarkeit: wird geladen...
Preis wird geladen...
CloneID: 7c6

Antigen Long Description: Murine antibodies were produced by immunising BALB/c mice with residues 686-696 (SSINEEITPRRQS) of human BCR fused to thyroglobulin. Hybridomas were generated by fusion of immunised cells with the myeloma cell line P3X63Ag8 via established methods.

Buffer Composition: PBS only.

Chimeric Use Statement: This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.

Specificity Statement: This antibody is specific for the SSINEEITPRRQS epitope of BCR (residues 686-696), and as such is able to recognise full-length BCR and the p210 form of the BCR-ABL fusion protein. p210 BCR-ABL is a cytogenetic marker of chronic myelogenous leukaemia, resulting from gross chromosomal translocation resulting in the 'Philadelphia chromosome'. The fusion protein is a constitutively active tyrosine kinase, causing deregulated downstream signalling and increasing likelihood of oncogenic transformation.

Application Notes (Clone): It has been shown by Western blot that 7c6 binds wildtype, full-length BCR and the p210 BCR-ABL fusion protein.
Mehr Informationen
Artikelnummer ABAAb00817-13.12-BT
Hersteller Absolute Antibody
Hersteller Artikelnummer Ab00817-13.12-BT
Verpackungseinheit 1 mg
Mengeneinheit STK
Reaktivität Human
Klonalität Recombinant
Methode Immunofluorescence, Immunoprecipitation, Western Blotting, Immunohistochemistry
Isotyp IgG4-S228P kappa
Wirt Human
Produktinformation (PDF) Download
MSDS (PDF) Download